Metropolis & Panacea Biotec launch Pan Metro Card

2206 Investors following Panacea Biotec. Share this News with them.

0

Like this story, share it with millions of investors on M3

Metropolis & Panacea Biotec launch Pan Metro Card

Metropolis Health Services (I) Ltd, India’s premier corporatised diagnostic centre chain, in association with Panacea Biotec, one of India’s leading companies in Nephrology & Kidney Transplantation, Friday launched ‘Pan Metro Card’

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Metropolis ties up with Star Clinic Metropolis gives diagnostic testing srvcs to KMRI Hospital Buy Panacea Biotec, target of Rs 536: Emkay ALSO READ See latest News about Panacea Biotec See previous management interviews See what other Experts & Brokerages are saying about Panacea Biotec Panacea Biotec BSE | NSE 25/05/12 Are Mutual Funds betting on Panacea Biotec?

Metropolis Health Services (I) Ltd, India's premier corporatised diagnostic centre chain, in association with Panacea Biotec , one of India's leading companies in Nephrology & Kidney Transplantation, Friday launched 'Pan Metro Card' - an economical way to avail the best in renal diagnostics. The family card will be available to patients associated with Panacea Biotec in Delhi and Mumbai initially, and offers up to 25% discount on renal diagnostic tests.

The launch of the Pan Metro Card was done at the ISNCON (Indian Society of Nephrology conference) 2007 in Delhi. Around 800 Nephrologists graced the occasion.

Mr. Sunil K Bajaj, Vice President, Panacea Biotec said, "We are delighted to offer this value added service in association with Metropolis - the most trusted brand in diagnostic testing. We are leaders in Nephrology & Transplantation segment and are driven to provide the best products/services to our customers. The Pan Metro card would offer the patient and his family the best way of availing excellent services at an economical rate. We expect at least 2,000 of our patients to benefit from this on an immediate basis. We vision this to eventually extend to more than 10,000 patients in the coming 6 years."

Dr. Dr G. S. K. Velu, Managing Director, Metropolis Health Services said the alliance was of strategic significance to Metropolis' growing credibility in the healthcare circles. "The association is a reinstatement of the quality, trust, efficiency Metropolis commands in our sphere. We are among the less-than-1% accredited labs in the country! We are the only laboratory to have a doctor spearheading each and every branch across the country. We take pride in associating ourselves with industry pioneers such as Panacea Biotec from time and again to offer the best in the diagnostic space. Patients afflicted with renal diseases/disorders have to regularly undergo numerous tests; at least once a week or fortnight for patients undergoing renal dialysis. The costs of the tests range between Rs. 400 - Rs. 10,000. With the card, a patient can avail up to 25% discount on renal diagnostic tests. Also Creatinine Test (detects kidney disorder) will be available free of charge for the card holders. This way, the patients can avail the best services at an economical rate."

The alliance is among the many initiated by Metropolis on an all-India basis to position itself as the numero-uno when it comes to accurate, advanced diagnostics. Metropolis is committed to continued excellence and is on a high growth trajectory - it has grown to being an over Rs. 140 crore chain from Rs. 9 crores in 2001-02. Metropolis has continuously evolved itself to meet the growing needs of the industry and at the same time keeping in mind at every step the convenience and comfort of the end consumer. It has the capability to carry out over 3,600 routine, specialized and highly specialized investigations with over 100 technologies including Biochip and DNA sequencing and is the organization which offers pathology and radiology as a composite unit under one roof.  

Sourced From: Blue Lotus Communications Pvt. Ltd